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Characterisation of SEQ0694 (PrsA/PrtM) of
Streptococcus equi as a functional peptidyl-prolyl
isomerase affecting multiple secreted protein
substrates†
Felicia Ikolo,ab Meng Zhang,a Dean J. Harrington,c Carl Robinson,d
Andrew S. Waller,d Iain C. Sutcliffe*a and Gary W. Blacka
Peptidyl-prolyl isomerase (PPIase) lipoproteins have been shown to influence the virulence of a number
of Gram-positive bacterial human and animal pathogens, most likely through facilitating the folding of
cell envelope and secreted virulence factors. Here, we used a proteomic approach to demonstrate that
the Streptococcus equi PPIase SEQ0694 alters the production of multiple secreted proteins, including at
least two putative virulence factors (FNE and IdeE2). We demonstrate also that, despite some unusual
sequence features, recombinant SEQ0694 and its central parvulin domain are functional PPIases. These
data add to our knowledge of the mechanisms by which lipoprotein PPIases contribute to the virulence
of streptococcal pathogens.
Introduction
In order to interact with their environments, bacteria translocate
significant numbers of proteins across their plasmamembranes,
either for eventual release (secretion) or for localisation within
the cell envelope.1–3 In pathogens, this ‘secretome’ plays a vital role
in host–pathogen interactions and consequently the mechanisms of
protein translocation are of much interest as ‘virulence-associated’
functions. Proteins exported by the Sec translocase emerge on the
extracytoplasmic side of the plasmamembrane as unfolded proteins
and the subsequent correct folding of these proteins is therefore
critical to their functioning. In ‘diderm’ bacteria (those with outer
membranes), a variety of periplasmic chaperones are required
to allow protein folding in the periplasm and/or translocation
across or into the outer membrane.1,4 In monoderm Gram-
positive bacteria, secreted proteins fold at the membrane-wall
interface with the assistance of a range of accessory components
of the Sec translocase.5 These include proteins belonging to the
peptidyl-prolyl Isomerase (PPIase) family, which assist protein
folding by catalysing cis–trans isomerisation of the peptide
bond preceding proline residues.6,7 In many Gram-positive
bacteria, these PPIases are N-terminally lipid-anchored lipoproteins,
presumably because the localisation of a PPIase peripheral to the
plasmamembrane surface places it in an optimal position to engage
with substrate proteins emerging from the Sec translocon.8
Several lipoprotein PPIases have been shown to have significant
roles in bacterial physiology, notably PrsA in Bacillus subtilis.9
Moreover, in some pathogens PPIases have been shown to aﬀect
virulence,7 including PrsA of Bacillus anthracis,10 Enterococcus
faecalis EF0685 and EF1534,11 Listeria monocytogenes PrsA2,12,13
Streptococcus pneumoniae SlrA and PpmA14 and Streptococcus
pyogenes PrsA.15 Some of these PPIase belong to the cyclophilin
subfamily (e.g. S. pneumoniae SlrA; E. faecalis EF1534) but many
belong to the parvulin subfamily,16 including the members of
PrsA family that appear to be ubiquitous in Firmicute genomes.
Streptococcus equi is the causative agent of the widespread
equine disease Strangles.17,18 We have previously shown that
the PrsA homologue of S. equi (UniProt: C0M9L5, originally
denoted PrtM) plays a significant role in S. equi virulence, both
in an air interface tissue culture model, a mouse model and,
most significantly, in the equine host.19 PrtM is here referred to
as SEQ0694, based on its annotation in the S. equi genome.17
To further investigate the role of SEQ0694 we have here
characterised the recombinant protein as a functional PPIase
and used a proteomic approach to demonstrate that SEQ0694
likely influences the folding and activity of multiple secreted
aDepartment of Applied Sciences, Faculty of Health & Life Sciences,
University of Northumbria at Newcastle, Newcastle upon Tyne, NE1 8ST, UK.
E-mail: iain.sutcliﬀe@northumbria.ac.uk; Fax: +44 (0)191 227 3519;
Tel: +44 (0)191 227 4071
bDepartment of Biochemistry, School of Medicine, St. George’s University,
True Blue, St. George’s, Grenada
cDivision of Biomedical Science, School of Life Sciences, University of Bradford,
West Yorkshire, BD7 1DP, UK
dCentre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford,
Newmarket, Suﬀolk CB8 7UU, UK
† Electronic supplementary information (ESI) available. See DOI: 10.1039/
c5mb00543d
Received 12th August 2015,
Accepted 8th October 2015
DOI: 10.1039/c5mb00543d
www.rsc.org/molecularbiosystems
Molecular
BioSystems
PAPER
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
8 
O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
3/
11
/2
01
5 
10
:5
8:
53
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal
Mol. BioSyst. This journal is©The Royal Society of Chemistry 2015
proteins of S. equi, including at least two putative virulence
factors.
Materials and methods
Bacterial strains and growth
S. equi strain 4047 (wild type) and its isogenic mutant strain
(DprtM138–213) with a deletion of codons 138 to 213 in seq0694
(i.e. lacking the central domain of SEQ0694, ESI,† Fig. S1) are
described in Hamilton et al.19 S. equi strains were grown in Todd
Hewitt media. Escherichia coli TOP10 and BL21 were grown in
LB media.
Production and purification of recombinant proteins
Genomic DNA from S. equi 4047 was isolated using a DNeasy
extraction kit (Qiagen). To produce recombinant N-terminally
His-tagged full-length SEQ0694 (rSEQ0694), the seq0694 ORF,
minus the sequence encoding the signal peptide, was amplified
from S. equi 4047 genomic DNA using the primer pair 50 GATC
GATC

C

A

T

A

T

GTGTCAGTCTACAAATGACAATACAAGTG 30 (for-
ward primer, NdeI site underlined) and 50 GATCGATC

C

T

C

G

A

GATATTTTTCTGACTTAGATTTAGAAGATTGAC 30 (reverse primer,
XhoI site underlined) and KOD Hot Start polymerase (Merck
Chemicals) according to the manufacturer’s instructions. The
amplified ORF was cloned into pET28a (Merck Chemicals)
using NdeI-XhoI and expressed in E. coli BL21(DE3) grown at
37 1C with shaking at 200 rpm, to an absorbance of 0.6 at
600 nm, in LBmedium supplementedwith 100 mgmL1 kanamycin.
Induction was performed by the addition of isopropyl-1-thio-b-D-
galactopyranoside to a concentration of 240 mg mL1, followed
by further incubation for 18 h at 30 1C with shaking at 100 rpm.
rSEQ0694 was purified according to the method of Malik et al.,20
except that the purified protein was concentrated and the buﬀer
exchanged into 18.2MO cm1water using 10 kDa cut-oﬀ centrifugal
concentrator units (Viva Science) The identity of rSEQ0694 was
confirmed by peptide mass fingerprinting of trypsinized bands
excised from Coomassie blue-stained SDS-polyacrylamide gels
(see below).
In addition to rSEQ0694, the section of the seq0694 ORF
encoding the predicted parvulin domain of SEQ0694 (amino
acids 148–242, ESI,† Fig. S1; rSEQ0694parv) was amplified using
primer pair TGCCATAG

C

A

T

A

T

GACTACTCAGGTCACTACTCTAG
ACAATG (forward, NdeI site underlined) and TGCCATAG

C

T

C

G

A

GTTAGGCTTTTTTGGTTACCTTAACA (reverse, XhoI site under-
lined), cloned, expressed and the protein purified as described
above, except that 5 kDa, 6 mL cut-off concentrator units (Viva
Science) were used.
The concentration of both purified proteins was determined
using the Bradford Assay.
Protease-coupled peptidylprolyl isomerase (PPIase) assay
The standard protease-coupled PPIase assay12,21 was employed
using three peptide substrates having a consensus sequence
Suc-Ala-X-Pro-Phe-pNA (Suc, succinyl; X = alanine, lysine or
phenylalanine; pNa, paranitroaniline). Assays were performed
by mixing 10 mL of purified rSEQ0694 (60 mg mL1) or rSEQ0694-
parv (40mgmL1) (diluted in 20mMHEPES, pH 7.4; 140mMNaCl;
10% v/v glycerol), cyclophilin (positive control) or diluent alone
(negative control) with 480 mL of buﬀer (20 mM HEPES, pH 7.4;
140 mM NaCl; 1 mM DTT) and allowing the mixture to equilibrate
on ice for 5 min. 10 mL of ice-cold chymotrypsin (20 mg mL1 in
0.001 M HCl; 0.002 M CaCl2) was pipetted into a cuvette in a
spectrophotometer (Spectronic Unicam Helios-a, Thermos Electron
Corporation), zeroed at 390 nm. The 490 mL ice-cold assay mixture
was quickly added to and mixed with the chymotrypsin, followed by
500 mL tetrapeptide substrate in ice-cold 20 mMHEPES, pH 7.4,
140 mM NaCl, 1 mM DTT, so as to give a final concentration of
37.5–75 mM peptide, and mixed quickly by pipetting. The final
chymotrypsin concentration in the reaction mixture was
0.2 mg mL1. The rate of the reaction (cis–trans isomerization)
was measured by following colour formation (absorbance at
390 nm) resulting from pNA release from the trans form of the
tetrapeptide substrate by chymotrypsin, for a maximum of 6 min.
Spectrophotometric readings were recorded automatically via
Vision 32 (Unicam Ltd) software.
Reported kinetic data are given as the mean value of triplicate
measurements for every condition. To ascertain if these data
reflected true Michaelis–Menten kinetics, a Lineweaver–Burk plot
was constructed and used to determine value of Km (calculated by
reciprocalising the X intercept in the Line-weaver-Burk plot). The
specificity constant (M s) was determined by dividing Kcat by Kma.
Effect of chymotrypsin on rSEQ0694 and rSEQ0694parv
recombinant proteins
To determine if chymotrypsin had any significant eﬀect on the
recombinant proteins, 10 mL purified rSEQ0694 (60 mg mL1)
or rSEQ0694parv (40 mg mL1) was incubated with chymotrypsin
(10 mL, 20mgmL1) in 880 mL assay buﬀer (20mMHEPES, pH 7.4;
140 mMNaCl; 1 mM DTT) for 20 s, 2 min and 5 min at 0 1C. The
reaction was stopped by the addition of 100 mL 10 mM PMSF and
subsequent incubation for 5 min at 0 1C. Incubations containing
rSEQ0694 or rSEQ0694parv incubated with PMSF-inactivated
chymotrypsin, chymotrypsin with PMSF, chymotrypsin alone,
recombinant proteins with PMSF and recombinant proteins alone
served as controls. The reactions were analyzed by SDS-PAGE.
Proteomic & bioinformatic methods
To compare protein expression in S. equi 4047 and DprtM138–213,
the strains were grown to mid-log phase in Todd Hewitt broth,
harvested by centrifugation and total cell proteins prepared as
described previously.22,23 After removal of cells, supernatant
proteins were precipitated with 100% (w/v) trichloroacetic acid,
washed three times with ice-cold acetone and processed as for
total-cell proteins. Two dimensional electrophoresis (2DE) and
protein spot identification following trypsinolysis and mass
spectrometry were performed as described previously.22,23 Only
proteins identified with Z2 peptide matches and Mascot total
scores Z50 were included.
Protein sequence alignments were performed using Clustal
Omega24 (http://www.ebi.ac.uk/Tools/msa/clustalo/).
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Physiological tests
Survival of S. equi strains in saline solutions was tested by
resuspending early stationary phase cells in 0, 0.9%, 14.7% or
29.4% NaCl w/v essentially as described by Reﬀuveille et al.25
Cell suspensions were sampled after 24 and 48 h by serial
dilution to 103 in the same medium and then plated on Todd
Hewitt agar plates for enumeration of surviving colony forming
units. Antibiotic sensitivity testing was performed by the standard
disc diﬀusion method using discs containing ampicillin (10 mg per
disc), penicillin G (6 mg per disc), streptomycin (500 mg per disc),
norflaxacin (5 mg per disc) and vancomycin (30 mg per disc). Zones
of inhibition were measured after 48 h incubation.
Results and discussion
rSEQ0694 encodes a functional PPIase
Our earlier study of S. equi SEQ069419 confirmed that this
lipoprotein is needed for full virulence but did not directly
address its function. Bioinformatic analyses indicated that
SEQ0694 exhibits significant pairwise homologies to members
of the PrsA/parvulin family of PPIases. In Firmicutes, these
proteins typically contain a central parvulin domain, flanked
by N- and C-terminal domains with likely additional chaperone
functions or roles in substrate recruitment,13,26,27 although
these flanking domains show limited sequence homology
(ESI,† Fig. S1). Notably, the parvulin domains of streptococcal
and lactococcal PrsA/PrtM family members have been noted to
lack key conserved residues13,28 (see below) and both L. lactis
PpmA and S. pneumoniae PpmA apparently lack PPIase activity,14,29
although it is notable that these proteins can complement some,
but not all phenotypes, of a L. monocytogenes prsA2 mutant.30
To confirm in vitro PPIase activity of SEQ0694, we produced
full-length SEQ0694 as a recombinant protein, rSEQ0694 (ESI,†
Fig. S2), for assay using a standard protease-coupled PPIase assay
in which the rate of cis to trans isomerisation of a tetrapeptide
substrate is measured through selective and colourigenic chymo-
trypsin hydrolysis of the trans isomer.12,21 In addition we produced
the central parvulin domain of SEQ0694 as a recombinant protein,
rSEQ0694parv. Both recombinant proteins were assayed against
three tetrapeptide substrates varying in the amino acid preceding
the critical proline residue. Whereas no activity could be detected
using tetrapeptide substrates containing lysine–proline or alanine–
proline bonds (data not shown), both rSEQ0694 and rSEQ0694parv
were found to exhibit PPIase activity using Suc-Ala-Phe-Pro-Phe-
pNA as substrate (Fig. 1). However, both recombinant proteins
exhibited notably lower activities than the calf thymus cyclophilin
used as a positive control.
Recombinant protein stability to chymotrypsin under the assay
conditions was assessed. Significant cleavage of rSEQ0694parv
by chymotrypsin was observed (ESI,† Fig. S3), whereas rSEQ0694
remained relatively stable for up to 5 min. This meant that
although rSEQ0694parv showed an apparently faster rate of
reaction compared with rSEQ0694 (Fig. 1), enzyme kinetics
could only be determined for the latter (Fig. 2). A Kcat Km
1 of
5.84  106/M s for rSEQ0694 was calculated from triplicate
PPIase assays, suggesting that rSEQ0694 is a moderately active
PPIase compared to other members of the parvulin family, with
a similar activity to E. coli PpiC (Table 1). This activity was
somewhat surprising as sequence alignments indicate that several
amino acids considered functionally significant in parvulins31–35
Fig. 1 Protease coupled PPIase assay with (A) 37.5, (B) 50 and (C) 75 mM
Suc-Ala-Pro-Phe-pNA peptide substrate. Blue = negative control, red =
cyclophilin (positive control), green = rSEQ0694 (full mature protein).
purple = rSEQ0694parv (central domain).
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are not conserved in rSEQ0694 (Fig. 3). However, a candidate
Asp (D187) which might fulfil the role of the critical conserved
Asp/Cys could be identified in rSEQ0694 (Fig. 3). Although a role of
this Asp/Cys as a catalytic nucleophile is not yet fully resolved,36 its
conservation in rSEQ0694 is likely to be significant. Moreover, the
conserved residues in bacterial PrsA proteins identified by Jakob
et al.26 are well conserved in SEQ0694 (ESI,† Fig. S1).
Proteomic analyses to identify putative SEQ0694 substrates
Having established that rSEQ0694 is a bona fide PPIase in vitro,
we were interested to further explore the nature of its substrates.
As SEQ0694 is a lipoprotein, we hypothesized that its substrates
would be secreted proteins emerging from the Sec translocase,
which need to fold rapidly en route to secretion. Misfolded
proteins are typically turned over rapidly by extracytoplasmic
proteases such as HtrA family members.37 Proteomic approaches
have therefore been used to identify extracytoplasmic proteins
for which folding is dependent on a lipoprotein PPIase.9,12,38,39
Thus we used proteomics to analyse diﬀerential protein expression
in the proteomes of S. equi 4047 and an isogenic mutant,
DprtM138–213, expressing a SEQ0694 N + C domains fusion
protein lacking much of the central parvulin domain of
SEQ069419 (Fig. 3). Note that as the seq0694 mutant strain was
originally designated DprtM138–213
19 for consistency we have retained
this designation.
Master 2D PAGE gels from 6 matched gel pairs (ESI,† Fig. S4)
were analysed for diﬀerential protein expression and significant
spots identified by mass spectrometry (Tables 2 and 3). Of the
detectable total cell proteins, 12 diﬀerentially expressed proteins
in 10 spots were identified (Table 2). The changes were primarily
in cytoplasmic enzymes (e.g. enolase) which, because the proteins
fold in the cytoplasm, may reflect general responses to stress due to
lack of fully functional SEQ0694 (see below). Four of these proteins
were also detected in the cell-free supernatant proteins (Table 3). In
the cell-free supernatant proteomes, 13 proteins in 17 spots were
found to be diﬀerentially expressed. As expected, the majority of
these are proteins predicted to be either secreted or cell envelope
localised and because of this could be plausible substrates for
SEQ0694 (Table 3). As multiple proteins were found to be absent
from the cell-free supernatant proteome of the mutant strain
DprtM138–213, we hypothesise that SEQ0694 is likely to influence
folding and secretion of multiple substrates rather than a specific
substrate. Interestingly, two previously reported virulence factors of
S. equi were notably absent from the cell-free supernatant proteome
of the DprtM138–213 mutant: the truncated fibronectin-binding
protein FNE40–42 and IgG endopeptidase IdeE2.43 FNE is noted to
be misannotated as a pseudogene in the strain 4047 genome17 due
to a misplaced start methionine. Our data therefore confirm the
expression of FNE by strain 4047. SEQ0882, a putative DNase
virulence factor homologous to S. pyogenes DNAse44 was also absent
from the cell-free supernatant proteome of the DprtM138–213 mutant.
Cumulatively, these proteomic changes likely explain, at
least in part, the attenuation of the DprtM138–213 mutant.
19
Fig. 2 Kinetic analysis of rSEQ0694. The Kcat for rSEQ0694 was determined
to be 583.75 s1 and the Km 100 mM. Calculated Kcat/Km is 5.84  10
6M1 s1.
Table 1 Comparison of the activities of parvulin family members
Parvulin Substratea Kcat/Km/M s Ref.
rSEQ0694 Phe 5.8  106 This study
rSEQ0694 Lys Inactive This study
rSEQ0694 Ala Inactive This study
B. subtilis PrsA Lys 1.5  104 27 and 33
B. subtilis PrsA Ala 0.6  104b 33
B. subtilis PrsA Glu 0.8  104b 33
S. aureus PrsA Lys 0.5  104b 33
S. aureus PrsA Ala 1.7  104b 33
S. aureus PrsA Glu 3.3  104 33
E. coli PpiC (Par10) Leu 1.3  107 46
E. coli PpiC (Par10) Ser 3.7  105 47
E. coli PpiD (Par68) Ala 1.1  109c 48
E. coli PpiD (Par68) Glu 3.4  109c 48
E. coli PpiD (Par68) Leu 2.3  109c 48
Human Pin4 (Par14) Arg 3.9  103 46
L. lactis PpmA Ala Inactived 29
S. pneumoniae PpmA Ala, Phe, Gly, Val, Leu, Gln, Glu Inactive 14
a Data from protease-coupled assays where substrate is a colourigenic tetrapeptide Succ-Ala-X-Pro-Phe-pNA in which X is the amino acid indicated in the
Table. b Estimation from Fig. 1 in Heikkinen et al.33. c Subsequently Weininger et al.49 have reported that PpiD is inactive as a PPIase using modified
substrates in a protease-free assay. d Data from a protease-free assay using the tetrapeptide Succ-Ala-Ala-Pro-Phe-2,4-difluroanilide as substrate.
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However, as the DprtM138–213 mutant should still express a N + C
domain fusion protein (lacking most of the parvulin domain), it
may be that more dramatic proteome changes would be evident
in an seq0694 null mutant, since a L. monocytogenes PrsA N + C
construct partly complemented the proteome defect of a full prsA
deletion12 and an N + C fusion construct of B. subtilis PrsA
partially restored secretion of an AmyQ reporter protein (although it
did not restore viability to PrsA-depleted cells27). In B. subtilis,
the N and C domain is notable in driving dimerization of PrsA
and, although lacking primary sequence homology, has structural
similarity to other ‘foldases’ such as trigger factor.26 Without
structural characterisation of the N + C fusion encoded by the
Fig. 3 Sequence alignment of SEQ0694 with representative members of the parvulin family. Alignment produced with Clustal Omega. The signal
peptide sequences of the Firmicutes proteins have been removed so that each sequence starts from the lipidated cysteine at the N-terminus of the
mature protein. Key active site residues of the characterised parvulins are highlighted in yellow. For the longer bacterial sequences, the region aligning
with the short E. coli PpiC sequence corresponds to the central parvulin domain. Realignment of the gapping in the central parvulin domain region in
SEQ0694 could bring D187 into alignment with the critical D/C residue present in the characterised parvulins. The position of the region deleted in the
S. equi mutant strain DprtM138–213
19 is shown in bold. Abbreviations and UniProt accession codes for the sequences are: Bsu_PRSA (Q81U45); B. subtilis
PrsA (P24327); Eco_PpiC, E. coli PpiC/Par10 (P0A9L5); Hsa_Par14, Homo sapiens Pin4 (Q9Y237); LMO_PrsA2, L. monocytogenes PrsA2 (Q71XE6);
Sau_PrsA, Staphylococcus aureus PrsA (A6QI23); and SEQ0694, S. equi PrsA (C0M9L5).
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S. equi DprtM138–213 mutant we cannot speculate whether this
construct is likely to have a native-like conformation and
functionality. However, it is notable that the sequence deletion
removes not only the majority of the parvulin domain of
SEQ0694 but also a conserved lysine of the Firmicutes PrsA
protein N-domains. It is worth reemphasising that the partial
deletion in the S. equi DprtM138–213 mutant is sufficient to cause
significant attenuation of virulence in the natural host.19
It was interesting to note that SEQ1657, a cyclophilin PPIase
lipoprotein (orthologous to S. pneumoniae SlrA14 and L. lactis
PpiA29) was up-regulated in both the total cell and secreted
proteins of the parental strain. Likewise, it was observed that
the SEQ1171 sortase is up-regulated in the mutant strain, perhaps
suggesting a need to remodel protein localisation within the
mutant cell envelope.
As the proteomic data suggested a range of protein functions
are likely to be perturbed in strain DprtM138–213, including
stress responses, we performed several physiological tests.
Although the mutant strain grows normally in nutrient rich
broth, we observed pleiotropic changes including increased
sensitivity to salt stress (ESI,† Table S1) and increased sensitivity
to various antibiotics with diverse cellular targets (ESI,†
Fig. S5). Increased sensitivity to salt stress has previously been
observed in a prsA mutant of E. faecalis11 and a prsaA2 mutant
Table 2 Proteins identified in differentially expressed spots on 2DE of cell associated protein extracts of S. equi 4047 compared to its isogenic mutant
producing an internally deleted SEQ0694
Spot #a
Protein
identifiedb Scorec
Matched
peptidesd % covere Predicted function f Signal peptide
WT2201 SEQ0898 1229 17 54 Enolase (PF00113,PF03952) No
WT2201 SEQ1657 117 3 8 Cyclophilin PPIase (PF00160) Lipoprotein
WT2201 SEQ0210 91 2 26 10 kDa chaperonin GroES (PF00166) No
WT3201 SEQ1366 206 5 14 Xaa-His dipeptidase (PF01546) No
WT3601 SEQ0434 158 3 14 Mannose-6-phosphate isomerase (PF01238) No
WT4001 SEQ0408 318 6 68 30S ribosomal protein S6 (PF01250) No
WT4204 SEQ1025 188 3 25 Asp23 domain protein (PF03780) No
WT5302 SEQ1354 184 3 23 Purine nucleoside phosphorylase (PF01048) No
WT5504 SEQ0046 293 6 30 Alcohol dehydrogenase (PF00107,PF08240) No
WT6201 SEQ1418 163 4 26 Putative dTDP-4-keto-6-deoxyglucose-3,5-epimerase (PF00908) No
WT6501 SEQ1011 408 6 22 6-Phosphofructokinase (PF00365) No
Prt9401 SEQ1642 103 3 23 Ribosome-recycling factor (PF01765) No
a Spot marked in ESI, Fig. S4. WT spots are upregulated or only detected in the wild type strain 4047, Prt spots were only detected in the DprtM138–213
mutant proteome. b As annotated in Holden et al.17 c Mascot score. d Number of non-redundant peptides identified for each protein. e Percent
amino acid coverage of entire protein. f As determined from Uniprot annotation, BlastP and PFAM analysis.
Table 3 Proteins identified in differentially expressed spots on 2DE of supernatant extracts of S. equi 4047 compared to its isogenic mutant producing
an internally deleted SEQ0694. WT spots are upregulated or only detected in the wild type strain 4047, Prt spots were only detected in the mutant
DprtM138–213 proteome
Spot #a
Protein
identifiedb Scorec
Matched
peptidesd % covere Predicted function f Signal peptide
WT1002 SEQ0210 174 4 57 10 kDa chaperonin GroES (PF00166) No
WT1401 SEQ1821 334 4 38 PepSY (PF03413) protease inhibitor domain lipoprotein Lipoprotein
WT1402 SEQ1177 198 5 22 Domain of Unknown Function (PF06207/DUF1002) Present
WT2101 SEQ1800 119 2 30 Unknown function, no conserved domains. Restricted
distribution within streptococci; spot position shifted
compared to mutant Prt1103
Present
WT2202 SEQ1025 146 3 20 Asp23 domain protein (PF03780) No
WT2202 FNE 72 2 6 Truncated fibronectin binding protein (PF08341) Present
WT2401 SEQ1177 526 8 36 Domain of unknown function (PF06207/DUF1002) Present
WT3301 SEQ1657 409 6 35 Cyclophilin type PPIase (PF00160) Lipoprotein
WT7301 SEQ0882 519 7 39 DNA/RNA non-specific endonuclease Present
WT7301 FNE 361 6 26 Truncated fibronectin binding protein (PF08341) Present
WT8401 SEQ0938 331 6 19 IdeE2 Mac family protein (PF09028) Present
WT8501 SEQ0938 204 4 11 IdeE2 Mac family protein (PF09028) Present
WT9202 FNE 221 5 13 Truncated fibronectin binding protein (PF08341) Present
WT9202 SEQ0882 93 3 14 DNA/RNA non-specific endonuclease Present
WT9403 SEQ0520 556 10 41 Hydrolase/esterase (PF07859) Present
Prt0301 SEQ1171 165 4 25 Sortase A (PF04203) Signal anchor
Prt1103 SEQ1800 133 3 36 Unknown function, no conserved domains. Restricted distribution
within streptococci; position shifted compared to mutant WT2101.
Present
Prt1202 SEQ1919 221 3 6 OppA olipopeptide binding lipoprotein (PF00496) Lipoprotein
Prt2101 SEQ0408 139 2 26 30S ribosomal protein S6 (PF01250) No
Prt2301 SEQ1919 86 3 6 OppA olipopeptide binding lipoprotein (PF00496) Lipoprotein
a Spot marked in ESI, Fig. S4. b As annotated in Holden et al.17 c Mascot score. d Number of non-redundant peptides identified for each protein.
e Percent amino acid coverage of entire protein. f As determined from Uniprot annotation, BlastP and PFAM analysis.
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of L. monocytogenes.30 A range of findings have been observed
regarding antibiotic susceptibilities of other prsA mutants.
Similar to our findings, a prsaA2 mutant of L. monocytogenes
displayed increased sensitivity to bacitracin, penicillin and
vancomycin but not gentamicin30 and a mutant in Staphylococcus
aureus prsA showed increased sensitivity to vancomycin.45 However,
a prsA mutant of E. faecalis was unaffected in its sensitivity to
ampicillin and norflaxin,11 in contrast to our findings. Cumulatively,
our data suggest a general perturbation in cell envelope function in
the DprtM138–213 mutant, which likely reflects multiple changes in
the extracytoplasmic proteome of the mutant (consistent with our
proteomic data). This is conclusion is consistent with the pleiotropic
effects of PrsA mutation in other Firmicutes.11,28,30,45
Conclusions
The data presented here confirm that rSEQ0694 is a moderately
active PPIase, despite lacking conservation of several amino
acids previously considered to be significant to the activity of
other parvulin PPIases. This observation thus focusses attention
on the conserved Asp/Cys identified as likely critical for catalysis.
Furthermore, proteomic experiments confirm that loss of the
lipoprotein PPIase activity in strain DprtM138–213 affects multiple
cell envelope proteins, including virulence factors, and is likely
to generate diverse phenotypic effects. As strain DprtM138–213 is
attenuated,19 these findings further suggest that streptococcal
PPIases, and PPIases generally,7 are interesting targets for novel
therapeutic strategies. By analogy with other bacterial PPIases,
it would also be of interest to determine whether the N- and
C-terminal domains of SEQ0694 possess additional chaperone
activities that contribute to post-translocational protein folding.
Abbreviations
pNa Paranitroaniline
PPIase Peptidyl-prolyl isomerase
rSEQ0694 Recombinant N-terminally His-tagged mature
SEQ0694
rSEQ0694parv Recombinant N-terminally His-tagged parvulin
domain of SEQ0694
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